ABIVAX announces its financial calendar for 2018

Paris, December 15th 2017 – (06:00pm CET) - ABIVAX (Euronext Paris: FR0012333284 – ABVX), a biotechnology company harnessing the immune system to develop a functional cure for HIV and treatments for inflammatory/autoimmune diseases and cancer, today provides its planned financial calendar for 2018, which is set as follows:

Date*

Announcement

Friday March 16, 2018

Publication of 2017 Financial Statements

Monday April 30, 2018

Publication and Release of the 2017 Annual Financial Report

Friday June 15, 2018

Annual Shareholders Meeting

Monday September 19, 2018

Publication of Financial Statements as of June 30, 2018

Friday September 28, 2018

Publication and Release of 2018 Half Year Report

* Subject to modification. Press releases are distributed either before the financial markets opening, or after the closure

 

All corporate information on the Company, such as its financial statements or its corporate presentations, is available on the Company’s website in the Investors’ section (www.abivax.com/en).